Literature DB >> 2655098

Carboplatin in refractory epithelial ovarian cancer.

J J Kavanagh1, C Nicaise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2655098

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

1.  Electrochemical Measurement of Dopamine Release and Uptake in Zebrafish Following Treatment with Carboplatin.

Authors:  Thomas M Field; Mimi Shin; Chase S Stucky; Joseph Loomis; Michael A Johnson
Journal:  Chemphyschem       Date:  2018-04-25       Impact factor: 3.102

2.  Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.

Authors:  G Los; E M Verdegaal; P H Mutsaers; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer.

Authors:  M E L van der Burg; R de Wit; W L J van Putten; A Logmans; W H J Kruit; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

4.  Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

Authors:  J A Gietema; G J Veldhuis; H J Guchelaar; P H Willemse; D R Uges; A Cats; H Boonstra; W T van der Graaf; D T Sleijfer; E G de Vries
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

5.  Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.

Authors:  Sam V Kaplan; Ryan A Limbocker; Rachel C Gehringer; Jenny L Divis; Gregory L Osterhaus; Maxwell D Newby; Michael J Sofis; David P Jarmolowicz; Brooke D Newman; Tiffany A Mathews; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2016-05-22       Impact factor: 4.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.